Invention Grant
- Patent Title: Deuterated tryptamine derivatives and methods of use
-
Application No.: US17394038Application Date: 2021-08-04
-
Publication No.: US11242318B2Publication Date: 2022-02-08
- Inventor: Alex Nivorozhkin , Michael Palfreyman
- Applicant: CYBIN IRL LIMITED
- Applicant Address: IE Dublin
- Assignee: CYBIN IRL LIMITED
- Current Assignee: CYBIN IRL LIMITED
- Current Assignee Address: IE Dublin
- Agency: DLA Piper LLP US
- Agent Robert Mino
- Main IPC: C07D209/16
- IPC: C07D209/16
Abstract:
The present disclosure is directed to chemical compounds and to the use of such compounds in the treatment of diseases associated with a serotonin 5-HT2 receptor.
Public/Granted literature
- US20210363104A1 DEUTERATED TRYPTAMINE DERIVATIVES AND METHODS OF USE Public/Granted day:2021-11-25
Information query
